Cleared Traditional

K893126 - DESERET(R) INTRODUCER SET WITH VITACUFF(R) DEVICE

K893126 is an FDA 510(k) clearance for DESERET INTRODUCER SET WITH VITACUFF DEVICE, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 General Hospital device with product code LJS cleared through the Traditional 510(k) pathway after a 107-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1989
Decision
107d
Days
Class 2
Risk

K893126 is an FDA 510(k) clearance for the DESERET(R) INTRODUCER SET WITH VITACUFF(R) DEVICE. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Sandy, US). The FDA issued a Cleared decision on August 10, 1989 after a review of 107 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K893126

510(k) Number K893126 FDA.gov
FDA Decision Cleared Substantially Equivalent - Direct De Novo (SESD)
Date Received April 25, 1989
Decision Date August 10, 1989
Days to Decision 107 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 129d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 302
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K893126.
EPICUTANEO-CAVA CATHETER CODE 2184
K897168 · Vygon Corp. · Apr 1990
PERCUTANEOUS INTRAVENOUS CATHETERS
K895712 · Pharmacia Deltec, Inc. · Dec 1989
DUAL LUMEN CATHETER FOR CHRONIC VASCULAR ACCESS
K892926 · Vas-Cath, Inc. · Dec 1989
PMT VASCULAR CATHETER MODEL NUMBER 3621-1
K883313 · Pmt Corp. · Oct 1988
MULTILUMEN CENTRAL VENOUS CATH. W/VITACUFF DEVICE
K882448 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1988
VITACUFF(R) PERCUTANEOUS INFECT. CONTROL KIT
K882100 · Vitaphore Corp. · Jul 1988